ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway.

J Cancer · 2020 · PMC7066020 · PMID 32201532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

However, some studies have shown that not all tumors exhibit high levels of ALDH3A1 expression, and the correlation between ALDH3A1 over-expression and estimation of tumor progression or prognosis may not be significant 22 , 23 .

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.